Memantine Treatment for Obsessive-compulsive Disorder and Generalized Anxiety Disorder

NCT00674219 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Obsessive-Compulsive Disorder
Generalized Anxiety Disorder

Interventions

DRUG: Memantine

Sponsor

University of California, Los Angeles

Collaborators

[object Object]